Drug-induced liver diseases (DILD) are clinico-pathologic patterns of liver injury caused by
drugs or other foreign compounds. Steatohepatitis is a rare form of DILD, and drugs account …

Drug-induced liver injury (DILI) is a common and underestimated cause of liver disease.
Several drugs and other xenobiotics can be the cause of different clinicopathologic patterns …

Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in developed
countries. Its frequency is increasing in the general population mostly due to the widespread …

Over the past decades, many drugs have been identified, that can potentially induce
steatohepatitis in the predisposed individual. Classically this has been incriminated to …

Some drugs may induce hepatotoxic lesions, such as steatosis or steatohepatitis found in
Non-Alcoholic Fatty Liver Disease (NAFLD). Among these drugs there are some anti-tumoral …

Drug-induced steatosis (DIS) and drug-induced steatohepatitis (DISH) are two of several
types of drug-induced liver injury (DILI). They can be caused by various drugs and may …

Introduction: Drug induced steatohepatitis (DISH), a form of drug induced liver injury (DILI) is
characterized by intracellular accumulation of lipids in hepatocytes and subsequent …

Hepatic steatosis is defined as fat deposition within hepatocytes (Fig. 1). It is seen
microscopically as vacuoles in a microvesicular or macrovesicular distribution …

In addition to the usual associations with insulin resistance, type 2 diabetes, central obesity,
and hypertriglyceridemia, nonalcoholic steatohepatitis (NASH) has been associated with …

Drug-induced steatohepatitis constitutes only a small fraction of the cases of steatohepatitis,
perhaps less than 2%; conversely, only a few drugs have unequivocally been shown to …